Year To Quarter End Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7597815

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Year to quarter end statement of income
Statement of income
Selling, general and administrative expenses
Remuneration for directors (and other officers)
87,825,000 JPY
84,375,000 JPY
Taxes and dues
34,038,000 JPY
33,305,000 JPY
Operating profit (loss)
-961,462,000 JPY
-852,231,000 JPY
Non-operating income
Interest income
70,000 JPY
227,000 JPY
Non-operating income
190,000 JPY
438,000 JPY
Non-operating expenses
Interest expenses
JPY
43,000 JPY
Non-operating expenses
2,793,000 JPY
7,578,000 JPY
Ordinary profit (loss)
-964,064,000 JPY
-859,372,000 JPY
Profit (loss) before income taxes
-964,064,000 JPY
-859,372,000 JPY
Income taxes - current
3,237,000 JPY
3,213,000 JPY
Income taxes
3,237,000 JPY
3,213,000 JPY
Profit (loss)
-967,302,000 JPY
-967,302,000 JPY
-967,302,000 JPY
-967,302,000 JPY
-862,585,000 JPY
-862,585,000 JPY
-862,585,000 JPY
-862,585,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.